Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin
Abstract Background Bariatric surgery is a widely adopted treatment for obesity and its secondary complications. In the past decade, microvesicles (MVs) and CD36 have increasingly been considered as possible biomarkers for obesity, the metabolic syndrome (MetSy), type 2 diabetes mellitus (T2DM). Thu...
Main Authors: | Jaco Botha, Morten Hjuler Nielsen, Maja Høegh Christensen, Henrik Vestergaard, Aase Handberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-018-0309-4 |
Similar Items
-
The effect of oxLDL on microvesicle release from platelets, measured by a sensitive flow cytometry method.
by: Tine Bo Nielsen, et al.
Published: (2015-11-01) -
BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals
by: Mathilde Sanden, et al.
Published: (2018-10-01) -
Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery
by: Gersina Rega-Kaun, et al.
Published: (2019-04-01) -
Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy
by: Jaco Botha, et al.
Published: (2017-01-01) -
Non-surgical complications following bariatric surgery
by: Polovina Snežana, et al.
Published: (2017-01-01)